Description and Brand Names
Información sobre medicamentos proporcionada por: IBM Micromedex
US Brand Name
- Unituxin
Descriptions
Dinutuximab injection is used in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), to treat children with high-risk neuroblastoma (a type of cancer that most often occurs in young children). This medicine is a GD2-binding monoclonal antibody.
This medicine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2020
Copyright © 2020 IBM Watson Health. Todos los derechos reservados. La información es de uso exclusivo para usuarios finales y se prohíbe su venta, redistribución o uso con fines comerciales.